Company Filing History:
Years Active: 2018-2020
Title: Masashi Kagihiro: Innovator in Pharmaceutical Formulations
Introduction
Masashi Kagihiro is a notable inventor based in Suita, Japan. He has made significant contributions to the field of pharmaceutical formulations, particularly focusing on obeticholic acid. With a total of 4 patents to his name, Kagihiro's work has the potential to impact the treatment of various diseases and conditions.
Latest Patents
Kagihiro's latest patents include innovative compositions of obeticholic acid and methods of use. These disclosures relate to formulations of obeticholic acid that exhibit improved stability, dissolution, and solubility. Furthermore, they detail methods for preparing these formulations for use and outline approaches for treating various diseases and conditions.
Career Highlights
Masashi Kagihiro is currently associated with Intercept Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work in the pharmaceutical industry has positioned him as a key figure in the development of effective treatments.
Collaborations
Kagihiro has collaborated with notable colleagues, including Richard Gail Lancaster and Kay Olmstead. These partnerships have contributed to the success of his projects and the advancement of pharmaceutical innovations.
Conclusion
Masashi Kagihiro's contributions to the field of pharmaceutical formulations, particularly through his work on obeticholic acid, highlight his role as an influential inventor. His ongoing research and collaborations promise to further enhance the landscape of medical treatments.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.